Orthobiologics Market to Reach US$ 8261.6 Mn by 2026, Growing Patient Awareness Drives Market | Fortune Business Insights

The global market for orthobiologics was valued at US$ 5830.1 Mn in the year 2018 and is anticipated to reach US$ 8261.6 Mn by the end of 2026. The Global Orthobiologics Market is projected to exhibit a CAGR of 4.5% throughout the forecast period.

Pune, India - May 16, 2019 /MarketersMedia/ —

The Global Orthobiologics Market is likely to gain traction on account of rising geriatric population, which in turn is indicative of the increasing prevalence of chronic arthritis. Fortune Business Insights published a report, titled “Orthobiologics Market Size, Share and Global Trend by Product Type (Viscosupplements, Bone Growth Stimulators, Demineralized Bone Matrix, Synthetic Bone Substitutes, Stem Cells, Allografts), Application (Spinal Fusion, Maxillofacial & Dental, Soft Tissue Repair, Reconstructive & Fracture Surgery), End User (Hospitals, Ambulatory Surgical Centers, Speciality Clinics) and Geography Forecast till 2025” which offers valuable insights into the drivers positively impacting the global market.

As per this report, the global market for orthobiologics was valued at US$ 5830.1 Mn in the year 2018 and is anticipated to reach US$ 8261.6 Mn by the end of 2026. The global orthobiologics market is projected to exhibit a CAGR of 4.5% throughout the forecast period.

Request Sample Copy at https://www.fortunebusinessinsights.com/enquiry/sample/orthobiologics-marke-100173

Demand for Spinal Fusion Method Expected to Increase

A lead analyst at Fortune Business Insights said, “Spinal fusion covered the highest share in the global orthobiologics market in 2018 owing to the rising prevalence of traumatic injuries and accidents.” “The advantages offered by orthobiologics regarding the treatment of spine-related injuries may fuel the demand for spinal fusion method,” he continued. Another application called soft tissue repair is anticipated to witness the highest growth on account of escalating demand for orthobiologics in cartilage repair. Rising incidence of sports injuries is also responsible for driving the soft tissue repair segment.

Favorable Reimbursement Policies Supports Growth in North America

From a geographical standpoint, North America is expected to lead the global orthobiologics market between 2028 and 2026. In 2018, the market for orthobiologics in North America has valued at US$ 2326.2 Mn. Favourable reimbursement policies in the U.S. and rising adoption of advanced orthobiologics therapies are key factors contributing to the market’s growth in the region. The rising demand for a better quality healthcare in North America is also expected to create growth opportunities for the orthobiologics market in the region. Trailing North America, Europe is the second most prominent region, covering a significant share in the global market for orthobiologics. Growth of the orthobiologics market in Europe is attributable to recent FDA approvals for orthobiologics products. The rising demand for viscosupplements and increasing number of orthopaedic clinics are factors driving the orthobiologics market in Asia Pacific.

BioFiber by Tornier and Similar Product Developments to Boost Growth

The global orthobiologics market is driven by emerging technologies in orthobiologics treatment. For instance, a technology called 3D printed implant offers better stability and significantly reduces surgery time. A global leader in orthopaedics called Tornier has launched BioFiber Surgical Mesh. This technology helps to repair ligament injuries and other muscle injuries. Growing geriatric population is another factor fuelling demand for orthobiologics products such as orthobiologics injections. The rising clearances for several orthobiologics products is driving the orthobiologics market during the forecast period. Other factors likely to boost the orthobiologics market include increasing demand for advanced treatment and high growth potential especially in emerging countries.

Stringent Regulations and High Cost May Restrict the Market to Grow

Although the orthobiologics market is growing considerably, there are some factors that may hamper the growth. These include high costs associated with orthobiologics treatment. People in low-income regions cannot afford such treatments and this may pose a serious threat to the growth of the orthobiologics market. Another factor hampering the market is strict approval process for orthobiologics treatment and products.

Browse Complete Report Details at https://www.fortunebusinessinsights.com/industry-reports/orthobiologics-marke-100173

NuVasive’s Launch of Propel DBM in 2018, to Boost its Market Position

Some of the leading players presently operating in the global orthobiologics market are Medtronic, Stryker, Sanofi, Zimmer Biomet, Bioventus, Sea Spine, Musculoskeletal Transplant Foundation, Wright Medical Group N.V., and RTI Surgical Holdings, Inc. Companies are focussing on launching new and technologically advanced orthobiologic products to increase their share in the orthobiologics market. For instance, NuVasive announced the launch of a new product called Propel DBM in 2018. This product helps to encourage bone growth among patients suffering from bone disorders.

About Us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Info:
Name: Fortune Business Insights
Email: Send Email
Organization: Fortune Business Insights
Address: Fortune Business Insights Pvt. Ltd. 308, Supreme Headquarters, Survey No. 36, Baner, Pune-Bangalore Highway, Pune - 411045, Maharashtra, India
Phone: +1 424 253 0390
Website: https://www.fortunebusinessinsights.com

Source URL: https://marketersmedia.com/orthobiologics-market-to-reach-us-82616-mn-by-2026-growing-patient-awareness-drives-market-fortune-business-insights/513471

Source: MarketersMedia

Release ID: 513471

More News From Biz Daily Online

Stock markets stabilize after tumble over trade dispute

May 19, 2019

BANGKOK — World stock markets turned higher on Tuesday, stabilizing after heavy losses on Wall Street, as investors monitor the escalating dispute between China and the U.S. over trade. The FTSE 100 in Britain rose 0.9% to 7,230, while France's CAC 40 advanced 1.2% to 5,324. Germany's DAX advanced 0.6% to 11,949. Futures augured an upbeat start on Wall Street, with the contract for the Dow Jones Industrial Average up 0.6% and that for the S&P 500, which on Monday suffered its biggest loss since January, adding 0.7%. Investors already rattled by mounting tensions between Beijing and Washington got an...

Shares mixed after trade tensions spark Wall Street sell-off

May 19, 2019

BANGKOK — Shares were marginally higher in Europe on Wednesday, despite broad losses in Asia and New York, after Germany reported stronger-than-expected industrial output data. Germany's DAX gained 0.3% to 12,125.80 following the report that industrial production rose 0.5 percent in March from the month before. The CAC 40 in France added 0.2% to 5,405.50, while Britain's FTSE 100 fell 0.1% to 7,253.71. U.S. futures edged higher, with the contract for the Dow Jones Industrial Average up 0.1% at 25,991.00. The S&P 500 future contract gained 0.1% to 2,892.50. A broad sell-off on Wall Street pulled the Dow 1.8%, or...

Chinese team heads to Washington to salvage trade talks

May 19, 2019

BEIJING — Efforts to end a U.S.-China trade war are in shambles after the United States accused China of reneging on its commitments and prepared to raise import taxes on $200 billion worth of Chinese goods. A Chinese delegation is headed to Washington to salvage talks aimed at resolving a dispute over China's aggressive push to challenge American technological dominance. Negotiations are set to resume Thursday. The setback in negotiations caught financial markets by surprise, and the U.S. stocks fell Tuesday for the second straight day. For weeks, Trump administration officials had suggested that negotiators were making steady progress. China...

World shares mixed as China affirms trade talks to go ahead

May 19, 2019

BEIJING — Global stock markets were mixed Tuesday after China said its economy czar will go to Washington for trade talks despite U.S. President Donald Trump's threat to escalate their tariff war. China's main stock index rose 0.7% and most other Asian markets also rebounded, while shares in Europe fell and Wall Street appeared headed for a lower open. The Chinese government said Vice Premier Liu He will go to Washington as planned despite fears he might cancel after Trump threatened to escalate a fight over Beijing's technology ambitions. That might help to keep alive hopes that the battle, which...

Asia stocks mostly higher after Trump trade threat

May 19, 2019

BEIJING — Asian stock markets rebounded Tuesday after Beijing said trade negotiators were preparing to go to Washington despite President Donald Trump's threat to escalate their tariff war. Benchmarks in Shanghai, Hong Kong and Sydney rose, while Tokyo declined after reopening following a long holiday. Trump's surprise threat Sunday of more tariff hikes triggered fears China might pull out of talks aimed at ending the fight over its technology ambitions. Markets recovered after Beijing said envoys were preparing to go to Washington. U.S. Trade Representative Robert Lighthizer said talks would start Thursday. There was no word on whether China's top...

About Us

Biz Daily Online gives a complete understanding of the world of business to you. Get today’s business news and learn about the trends that are affecting every business here.

Contact us: sales[at]bizdailyonline.com

Subscribe Now!